Sunflower Pharmaceutical Group Co.,Ltd

SZSE:002737 Stock Report

Market Cap: CN¥7.3b

Sunflower Pharmaceutical GroupLtd Management

Management criteria checks 2/4

Sunflower Pharmaceutical GroupLtd's CEO is Yi Guan, appointed in Jan 2019, has a tenure of 7.42 years. directly owns 0% of the company’s shares, worth CN¥5.09K. The average tenure of the management team and the board of directors is 4.5 years and 3.1 years respectively.

Key information

Yi Guan

Chief executive officer

CN¥4.8m

Total compensation

CEO salary percentagen/a
CEO tenure7.4yrs
CEO ownership0.00007%
Management average tenure4.5yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

Analysis Article • Jan 04

There Is A Reason Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Price Is Undemanding

With a price-to-earnings (or "P/E") ratio of 13.8x Sunflower Pharmaceutical Group Co.,Ltd ( SZSE:002737 ) may be...
Analysis Article • Nov 04

We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

Sunflower Pharmaceutical Group Co.,Ltd's ( SZSE:002737 ) lackluster earnings announcement last week disappointed...
Analysis Article • Aug 26

A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Key Insights The projected fair value for Sunflower Pharmaceutical GroupLtd is CN¥22.97 based on 2 Stage Free Cash Flow...
Analysis Article • Jul 19

Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Sunflower Pharmaceutical Group Co.,Ltd's ( SZSE:002737 ) price-to-earnings (or "P/E") ratio of 14x might make it look...
Analysis Article • Jun 07

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Sunflower Pharmaceutical Group Co.,Ltd ( SZSE:002737 ) will increase its dividend from last year's comparable payment...
Analysis Article • May 06

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Last week's earnings announcement from Sunflower Pharmaceutical Group Co.,Ltd ( SZSE:002737 ) was disappointing to...
Analysis Article • Apr 16

Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

With a price-to-earnings (or "P/E") ratio of 12.6x Sunflower Pharmaceutical Group Co.,Ltd ( SZSE:002737 ) may be...
Analysis Article • Mar 04

We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

CEO

Yi Guan (44 yo)

7.4yrs
Tenure
CN¥4,839,500
Compensation

Ms. Yi Guan has been a Non-Independent Director of Sunflower Pharmaceutical Group Co., Ltd. since September 26, 2017 and serves as its General Manager since January 07, 2019. She was awarded the title of H...

Leadership Team

NamePositionTenureCompensationOwnership
Yi Guan
GM & Non-Independent Director7.4yrsCN¥4.84m0.000070%
CN¥ 5.1k
Chunhong Wu
Financial Manager4.5yrsCN¥790.80kno data
Yang Yang
Deputy GM & Non-Independent Director1.3yrsCN¥21.70kno data
Guangguang Zhou
Board Secretary4.4yrsCN¥426.10kno data
Xin Ma
Deputy General Manager4.5yrsCN¥1.37mno data
Yang Hai
Deputy General Manager4.5yrsCN¥1.42mno data
Chao Guo
Deputy General Manager2yrsCN¥548.70kno data
Li Chen
Accounting Supervisorno datano datano data
Liang Chen
Deputy General Manager4.5yrsCN¥3.06mno data
Yang Hai
Deputy General Manager2yrsno datano data
Guang Tao Liu
Deputy General Manager1.3yrsno datano data
4.5yrs
Average Tenure
44.5yo
Average Age

Experienced Management: 002737's management team is considered experienced (4.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yi Guan
GM & Non-Independent Director8.8yrsCN¥4.84m0.000070%
CN¥ 5.1k
Yang Yang
Deputy GM & Non-Independent Director2yrsCN¥21.70kno data
Yanling Guan
Non-Independent Director12.3yrsCN¥1.41mno data
Jingshang Ren
Non-Independent Director8.8yrsCN¥50.80kno data
Yan He
Chairman of the Supervisory Board8.8yrsno datano data
Yuxiu Guan
Chairman7.4yrsCN¥2.20mno data
Fen Lan
Supervisor4.3yrsno datano data
Jianzhong Zhou
Non-Independent Director2yrsno datano data
Jiajun Miao
Independent Director2yrsCN¥130.00kno data
Ying Zhang
Independent Director2yrsCN¥130.00kno data
Yan Zhao
Independent director2yrsCN¥130.00kno data
Jian Cui
Non-Employee Supervisor2yrsno datano data
3.1yrs
Average Tenure
54.5yo
Average Age

Experienced Board: 002737's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/13 19:59
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sunflower Pharmaceutical Group Co.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.